Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,017 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BIOTECHNOLOGY VALUE FUND L P RPTX Repare Therapeutics Inc. Common Shares 13D 21.6% 3y
Flawless Management Inc. GASS StealthGas Inc. 13D/A 26.1% 3y
VALINOR MANAGEMENT, L.P. NEXT NextDecade Corp 13D/A 6.85% 3y
Corvina Holdings Limited GROV Grove Collaborative Holdings, Inc. 13D/A 21.1% 3y
Virgin Investments Limited SPCE Virgin Galactic Holdings, Inc 13D/A 8.4% 3y
EnCap Partners GP, LLC PR Permian Resources Corp 13G 15.04% 3y
EnCap Partners GP, LLC ESTE Earthstone Energy Inc. Class A Common Stock 13D/A 0% 3y
Argus Seller, LP NDAQ Nasdaq, Inc. 13D 14.84% 3y
Anson Funds Management LP NNDM Nano Dimension Ltd. 13D/A 8.7% 3y
Jeffrey Osher BEEP Mobile Infrastructure Corp 13D/A 62.6% 3y
Sherif Abdou, M.D. PIII P3 Health Partners Inc. 13D/A 9.3% 3y
Arturo R. Moreno CCO Clear Channel Outdoor Holdings, Inc. 13D/A 6.4% 3y
AK Jensen Investment Management Limited ASPI ASP Isotopes Inc. 13G 13.8% 3y
Satter Muneer A RNTX Rein Therapeutics, Inc. 13D/A 19.9% 3y
STILWELL JOSEPH SFBC Sound Financial Bancorp, Inc. 13D/A 15.4% 3y
AREX CAPITAL MASTER FUND, LP FRGI Fiesta Restaurant Group, Inc. 13D/A 0% 3y
Flawless Management Inc. IMPP Imperial Petroleum Inc./Marshall Islands 13D/A 29.3% 3y
Fairmount Funds Management LLC VRDN Viridian Therapeutics, Inc.DE 13D/A 19.99% 3y
Alessandra T. Norcross FRBK Republic First Bancorp Inc 13D/A 7.6% 3y
Laurence E. Hirsch MDAI Spectral AI, Inc. 13G 5.74% 3y
Commodore Capital LP HARP Harpoon Therapeutics, Inc. Common Stock 13G 9.9% 3y
TortoiseEcofin Sponsor III LLC TRTL TortoiseEcofin Acquisition Corp. III 13G/A 28.4% 3y
Engine Capital, L.P. OFIX Orthofix Medical Inc. 13D 7.3% 3y
Horton Capital Partners Fund, LP OSS One Stop Systems, Inc. 13D 5.35% 3y
Access Industries Management, LLC APGE Apogee Therapeutics, Inc. 13G 5.22% 3y
ADAGE CAPITAL PARTNERS GP, L.L.C. NKTX Nkarta, Inc. 13G 7.54% 3y
Kent Lake Capital LLC VAPO Vapotherm, Inc. Common Stock 13G 5.2% 3y
F. Hurst Lin (“Lin”) AUGX Augmedix, Inc. Common Stock 13D/A 10.9% 3y
Board of Directors of MetLife, Inc., as an entity MET Metlife Inc 13D/A 16% 3y
WHITE MOUNTAINS INSURANCE GROUP LTD MAX MediaAlpha, Inc. 13D/A 48.7% 3y
Soleus Capital Master Fund, L.P. YARW Yarrow Bioscience, Inc. 13G 6.4% 3y
TPG GP A, LLC TPG TPG Inc. 13D 80.4% 3y
TPG GP A, LLC HOUS Anywhere Real Estate Inc. 13D/A 8.9% 3y
Nextech Crossover I GP S.a. r.l. AMAM Ambrx Biopharma, Inc. Common Stock 13G 5% 3y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 12.66% 3y
Advance/Newhouse Partnership CHTR Charter Communications, Inc. 13D/A 12.4% 3y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G/A 11.78% 3y
Brookstone Capital Management BAPR Sageworth Trust Co 13G/A 6.22% 3y
Taconic Capital Advisors LP CCVI Churchill Capital Corp VI 13G/A 0% 3y
Saba Capital Management, L.P. BTX BlackRock Technology & Private Equity Term Trust 13D/A 13.8% 3y
Rubric Capital Management LP MREO Mereo BioPharma Group plc 13D/A 13.25% 3y
Coeur Mining, Inc. ASM Avino Silver & Gold Mines Ltd 13G/A 5.4% 3y
Brookstone Capital Management AAPR Innovator ETFs Trust 13G 12.2% 3y
BCE-Mach Aggregator LLC MNR Mach Natural Resources LP 13G 71.8% 3y
MILLENNIUM MANAGEMENT LLC EBIX Ebix Inc 13G 5.2% 3y
Bay Pond Partners, L.P. CUBI Customers Bancorp, Inc. 13G 5.09% 3y
EVR Research LP SSTI Soundthinking, Inc. 13G 5.7% 3y
Deep Track Capital, LP ALGS Aligos Therapeutics, Inc. 13G 9.99% 3y
Deep Track Capital, LP AMAM Ambrx Biopharma, Inc. Common Stock 13G 5.65% 3y
VIKING GLOBAL INVESTORS LP VKTX Viking Therapeutics, Inc. 13G 5.9% 3y